According to the American College of Radiology and Society of Breast Imaging, the recent article (O’Donoghue et al) regarding costs of national breast cancer screening published in the Annals of Internal Medicine (AIM) is misleading and provides an incomplete picture of costs and benefits of breast cancer screening programs.
Despite evidence that contralateral prophylactic mastectomy (CPM) does not improve survival rates, an increasing number of young women with breast cancer elect to remove their healthy breast to avoid recurrence and improve survival.